8-K//Current report
ANTARES PHARMA, INC. 8-K
Accession 0001564590-21-024525
CIK 0001016169operating
Filed
May 5, 8:00 PM ET
Accepted
May 6, 7:30 AM ET
Size
513.7 KB
Accession
0001564590-21-024525
Documents
- 8-Katrs-8k_20210506.htmPrimary
8-K
- EX-99.1atrs-ex991_6.htm
EX-99.1 PRESS RELEASE
- GRAPHICgbzjl4uq45ct000001.jpg
GRAPHIC
- EX-101.SCHatrs-20210506.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABatrs-20210506_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREatrs-20210506_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLatrs-8k_20210506_htm.xml
IDEA: XBRL DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001564590-21-024525-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001016169
Filing Metadata
- Form type
- 8-K
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 7:30 AM ET
- Size
- 513.7 KB